On October 29, 1959, the pharmaceutical company G.D. Searle filed an application with the U.S. Food and Drug Administration (FDA) to license their drug Enovid for use as an oral contraceptive.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback